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Bestrophinopathy: An RPE-Photoreceptor Interface Disease
Abstract
Bestrophinopathies, one of the most common forms of inherited macular degenerations, are caused by
mutations in the BEST1 gene expressed in the retinal pigment epithelium (RPE). Both human and canine
BEST1-linked maculopathies are characterized by abnormal accumulation of autofluorescent material
within RPE cells and bilateral macular or multifocal lesions; however, the specific mechanism leading to
the formation of these lesions remains unclear. We now provide an overview of the current state of
knowledge on the molecular pathology of bestrophinopathies, and explore factors promoting formation of
RPE-neuroretinal separations, using the first spontaneous animal model of BEST1-associated
retinopathies, canine Best (cBest). Here, we characterize the nature of the autofluorescent RPE cell
inclusions and report matching spectral signatures of RPE-associated fluorophores between human and
canine retinae, indicating an analogous composition of endogenous RPE deposits in Best Vitelliform
Macular Dystrophy (BVMD) patients and its canine disease model. This study also exposes a range of
biochemical and structural abnormalities at the RPE-photoreceptor interface related to the impaired coneassociated microvillar ensheathment and compromised insoluble interphotoreceptor matrix (IPM), the
major pathological culprits responsible for weakening of the RPE-neuroretina interactions, and
consequently, formation of vitelliform lesions. These salient alterations detected at the RPE apical
domain in cBest as well as in BVMD- and ARB-hiPSC-RPE model systems provide novel insights into the
pathological mechanism of BEST1-linked disorders that will allow for development of critical outcome
measures guiding therapeutic strategies for bestrophinopathies. © 2017 Elsevier Ltd
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Bestrophinopathies, one of the most common forms of inherited macular degenerations, are caused by
mutations in the BEST1 gene expressed in the retinal pigment epithelium (RPE). Both human and canine
BEST1-linked maculopathies are characterized by abnormal accumulation of autoﬂuorescent material
within RPE cells and bilateral macular or multifocal lesions; however, the speciﬁc mechanism leading to
the formation of these lesions remains unclear. We now provide an overview of the current state of
knowledge on the molecular pathology of bestrophinopathies, and explore factors promoting formation
of RPE-neuroretinal separations, using the ﬁrst spontaneous animal model of BEST1-associated retinopathies, canine Best (cBest). Here, we characterize the nature of the autoﬂuorescent RPE cell inclusions
and report matching spectral signatures of RPE-associated ﬂuorophores between human and canine
retinae, indicating an analogous composition of endogenous RPE deposits in Best Vitelliform Macular
Dystrophy (BVMD) patients and its canine disease model. This study also exposes a range of biochemical
and structural abnormalities at the RPE-photoreceptor interface related to the impaired cone-associated
microvillar ensheathment and compromised insoluble interphotoreceptor matrix (IPM), the major
pathological culprits responsible for weakening of the RPE-neuroretina interactions, and consequently,
formation of vitelliform lesions. These salient alterations detected at the RPE apical domain in cBest as
well as in BVMD- and ARB-hiPSC-RPE model systems provide novel insights into the pathological
mechanism of BEST1-linked disorders that will allow for development of critical outcome measures
guiding therapeutic strategies for bestrophinopathies.
© 2017 Elsevier Ltd. All rights reserved.
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1. Introduction
The retinal pigment epithelium (RPE) is an organized monolayer
of highly specialized cells responsible for a sustained interaction
with photoreceptors, a mission pivotal for normal visual function
and retinal preservation (Hageman and Johnson, 1991; Bok, 1993;
Strauss, 2005). These diverse functions are orchestrated by a
broad array of molecules designed to access speciﬁc cascades of
intra- and intercellular interactions in the retina (reviewed in:
Steinberg, 1985; Strauss, 2005; Kevany and Palczewski, 2010;
Bonilha, 2014). One of such RPE-speciﬁc molecules is BESTROPHIN 1 (OMIM #607854), a transmembrane channel protein
encoded by BEST1 gene and associated with the RPE basolateral
membrane (Marmorstein et al., 2000; Sun et al., 2002; Gomez et al.,
2013). Although BESTROPHIN 1 has been extensively studied and
described as a multifunctional protein implicated in mediating
anion transport, regulation of calcium signaling and cell volume
(Rosenthal et al., 2005; Hartzell et al., 2008; Strauss et al., 2014;
Kane Dickson et al., 2014; Yang et al., 2014; Milenkovic et al.,
2015), its multifaceted nature and complex interactions with photoreceptors in health and disease still remain elusive.
Mutations in BEST1 have been causally associated with several
clinically heterogeneous retinal disorders, collectively termed
bestrophinopathies (Petrukhin et al., 1998; Seddon et al., 2001;
Yardley et al., 2004; Schatz et al., 2006; Burgess et al., 2008;
Davidson et al., 2009; Boon et al., 2009a). The BEST1 mutational
spectrum underlying these retinopathies varies greatly, and involves over 200 distinct mutations (Boon et al., 2009a; Pasquay
et al., 2015; Yang et al., 2015). Additionally, a considerable variability in age at onset, rate of disease progression and phenotypic
expression has been reported, not only between unrelated patients
harboring the same mutation, but also among affected individuals
within a single family (Kramer et al., 2000; Kinnick et al., 2011;
Bitner et al., 2012; MacDonald et al., 2012; Boon et al., 2013). This
phenomenon of phenotypic and allelic heterogeneity highlights a
signiﬁcant phenotypic overlap among BEST1-linked disorders,
posing a challenge in both determining the diagnostic speciﬁcity as
well as predicting the outcomes of visual impairment. In recent
years, the complexity of genotype-phenotype correlation in
bestrophinopathies has proven difﬁcult to explain with traditional
models of disease pathogenesis (Allikmets et al., 1999; Boon et al.,
2007; Yu et al., 2007; Querques et al., 2009; Booij et al., 2010; Liu
et al., 2016), indicating a presence of potential genetic modiﬁers
or still undetermined Best1 protein interactors, involvement of
environmental components or a combination of both. This likely
would point to a complex interplay of genetic susceptibility factors
and modiﬁable environmental stimuli utilizing novel signaling
pathways in the retina.
The broad spectrum of clinical presentations in bestrophinopathies ranges from the widespread symptoms affecting peripheral

retina and vitreous in a rare condition of vitreoretinochoroidopathy
(ADVIRC; OMIM#193220) to the well-deﬁned clinical abnormalities restricted to the macula and central retina in Best Vitelliform
Macular Dystrophy (BVMD) and autosomal recessive bestrophinopathy (ARB). BVMD (a.k.a. VMD2, OMIM#153700), inherited as an
autosomal dominant trait with incomplete penetrance, and the
recessive form (ARB; OMIM#611809) are the most common and
best explored juvenile macular dystrophies among bestrophinopathies, characterized by a markedly abnormal electrooculogram
(EOG) accompanied by an excessive accumulation of lipofuscin
material within RPE cells, formation of focal and multifocal subretinal lesions, and consequently, loss of central vision (Pianta et al.,
2003; Boon et al., 2009b; Pasquay et al., 2015; Fung et al., 2015).
An abnormal accumulation of lipofuscin is a major risk factor
implicated in different forms of macular degeneration (Delori et al.,
1995a; Marmorstein et al., 2002; Gerth et al., 2007; Biarnes et al.,
2015), and also the most notable and consistent pathological
ﬁnding in BEST1-linked maculopathies, serving as an indirect
biomarker of metabolic activity between the photoreceptor outer
segment (POS) turnover and RPE phagocytosis (Bakall et al., 2007;
~ eiro-Gallego et al., 2011; Lei et al., 2013; Singh et al., 2013a).
Pin
Recent advances with noninvasive retinal imaging modalities have
enabled detailed mapping and quantiﬁcation of fundus autoﬂuorescence (FAF) in vivo, and its correlation with increased levels
of lipofuscin components in the aged and diseased retinae (Delori
et al., 1995a, 1995b; Brunk and Terman, 2002; Boon et al., 2008;
Duncker et al., 2014); however, the polymorphous nature of lipofuscin material and consequences of its buildup in the retina are
still controversial.
To begin to address these questions, we used the spontaneous
canine BEST1 disease model (cBest a.k.a. canine multifocal retinopathy, cmr) (Guziewicz et al., 2007, 2011; Zangerl et al., 2010;
Beltran et al., 2014; Singh et al., 2015) to characterize lipofuscin
ﬂuorophores in the cBest1 mutant RPE, and explore factors leading
to the formation of subretinal lesions in BEST1-associated maculopathies. This study highlights matching spectral proﬁles of the
native lipofuscin autoﬂuorescence between human and dog
bestrophinopathies, as well as robust biochemical and structural
alterations at the RPE-photoreceptor interface that trigger formation of vitelliform lesions.
2. Canine models of human BEST1-related dystrophies
Over the recent decades, hundreds of spontaneous genetic
conditions have been described in dogs, and most of them with
clinically and genetically close counterparts to the human disorders
(OMIA: http://omia.angis.org.au). The naturally occurring canine
models of inherited retinal disorders in man have proved crucial in
the investigation of disease mechanisms and development of new
therapeutic strategies (Acland et al., 2001; Kom
aromy et al., 2010;
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Beltran et al., 2012; Downs et al., 2016).
We have recently characterized a naturally occurring autosomal
recessive disorder in dogs, canine Best (cBest a.k.a. canine multifocal retinopathy, cmr), which is caused by the same genetic defects
as human bestrophinopathies, and captures the full range of clinical
manifestations observed in patients (Guziewicz et al., 2007, 2011;
Zangerl et al., 2010; Beltran et al., 2014; Singh et al., 2015). To
date, cBest retinopathy affects thirteen dog breeds worldwide and
results from any of the three distinct mutations identiﬁed in the
canine BEST1 (cBEST1) gene. The premature stop mutation located
in the ﬁrst coding exon of cBEST1 (c.73C > T/p.Arg25* alias R25X)
was recognized among Mastiff-related breeds (Guziewicz et al.,
2007, 2011); a missense change (c.482G > A/p.Gly161Asp alias
G161D) affecting cBest1 protein folding and trafﬁcking was
discovered in a rare breed of Coton de Tulear (Guziewicz et al., 2007,
2012); whereas the frameshift mutation (c.1388delC/p.Pro463fs
alias P463fs), truncating BESTROPHIN 1 C-terminus, was shown to
segregate in Lapponian Herders (Zangerl et al., 2010). All three
mutations lead to the consistent clinical phenotype in homozygous
affected dogs, and model all major aspects of the disease-associated
mutations as well as their molecular consequences described in
man (Guziewicz et al., 2007, 2011, 2012; Beltran et al., 2014; Singh
et al., 2015).
The spectrum of clinical and molecular features recapitulated,
including the salient predilection of lesions to the canine macular
region, makes cBest an extremely attractive model system not only
for addressing principles behind the molecular pathology of
bestrophinopathies, but also for validating new therapeutic strategies (Guziewicz et al., 2013; Beltran et al., 2014; Singh et al., 2015).
Currently, the loss of function model (cBest1-R25X), the C-terminal
deletion (cBest1-P463fs), and the compound heterozygous model
(cBest1-R25X/P463fs) harboring both mutations in a heterozygous
state, are available for research study. We used these translational
models as a platform for in-depth investigation of the pathogenic
sequence in BEST1-related disorders, and addressed the central
question in the disease pathogenesis, the intrinsic susceptibility of
the macula to its primary detachment in bestrophinopathies.
3. Lipofuscin as a pathological agent in BEST1-associated
maculopathies
3.1. Excessive buildup of lipofuscin within RPE: a hallmark of canine
and human bestrophinopathies
Retinal pigment epithelium has been recognized as a primary
target site for many retinal degenerative disorders, including
bestrophinopathies. Although the disease-causative gene product,
BESTROPHIN 1, has been associated with basolateral membrane of
RPE cells (Marmorstein et al., 2000; Strauss et al., 2014), the predominant clinical manifestations in BVMD and ARB patients pertain
to the abnormal apposition of RPE apical surface to the neurosensory retina, delineated by intense FAF signals in vivo and aggregation of autoﬂuorescent material when examined ex vivo (O'Gorman
et al., 1988; Spaide et al., 2006; Bakall et al., 2007; Sparrow et al.,
2016). As the canine Best's disease model mirrors both the
altered topographic cSLO-FAF distribution as well as the end-stage
pathological ﬁndings described in patients (Guziewicz et al., 2007;
Beltran et al., 2014; Singh et al., 2015), this model was used to
examine the spectral nature of the RPE-associated autoﬂuorescent
constituents using Hyperspectral Autoﬂuorescence Imaging (HAI)
technology (Gao et al., 2012; Smith et al., 2014).
Baseline evaluation of the wild-type canine retinae (age range:
10 mos-6 yrs) demonstrated a gradual increase in native autoﬂuorescence within RPE cells (Fig. 1A). This slow yet steady
augmentation of granular yellow to brown-tan deposits reﬂects the

natural aging process of the canine retina and, consistent with the
studies in human, increases over the dog's lifespan in a linear
manner (Fig. 1A). Furthermore, in agreement with clinical assessments in both BVMD and ARB patients (Boon et al., 2013; Sparrow
et al., 2016), the cBest model exhibits an abnormal distribution of
FAF intensities associated with focal and multifocal retinal detachments observed by in vivo imaging (Fig. 1B,C). Canine retinae
harboring a nonsense mutation (c.73C > T/p.R25X) in cBEST1 gene
do not express BESTROPHIN 1 protein, and show both, increased
FAF signals associated with areas of separations of the neural retina
from the underlying RPE, and an excessive accumulation of
lipofuscin-like material within RPE when compared to the agematched controls (Fig. 1BeE). Representative H&E and DIC images of cBest1-R25X-affected and control retinae are shown in
Fig. 1D,E. Canine cBest1-R25X/P463fs compound heterozygous and
cBest1-P463fs homozygous models (Zangerl et al., 2010; Beltran
et al., 2014) display similar pathological characteristics.
To investigate the nature of these RPE inclusions and address the
question of whether the buildup of the lipofuscin-like deposits
promotes development of focal to multifocal retinal detachments,
cBest samples with early pre-vitelliform and vitelliform lesions
from supero-temporal quadrant were selected for HAI and IHC
analyses (for details, see Supplementary Materials and Methods). The
HAI-determined spectral signatures derived from canine Best1R25X mutant samples were then compared to the HAI emission
proﬁles of human BVMD (hBest1-T6R and -Y227N) RPE (Mullins
et al., 2005, 2007), as well as to the healthy controls from both
species (Fig. 2). Comparative HAI analysis of endogenous RPE ﬂuorophores conﬁrmed the excessive accumulation of autoﬂuorescent material in BEST1 mutant as a common feature of both
human and canine bestrophinopathies (Fig. 2AeE), and further
revealed not only matching spectral proﬁles between Best1affected and control samples of dog (Fig. 2B,D) and human
(Fig. 2E), but also analogous emission proﬁles between human and
canine bestrophinopathies (Fig. 2F,G). Overall, the endogenous RPE
deposits emitted intense ﬂuorescent signals across the recorded
spectrum, with emission intensity, Iem, signiﬁcantly higher in
cBest1-R25X versus age-matched wild-type (WT) control (Iem 3
fold; ***p < 0.000002) across the interval as depicted in a box plot
(Fig. 2C). The spectral signature was highly comparable among all
samples examined, with a major emission peak at 536e569 nm
consistent with lipofuscin (Ben Ami et al., 2016), followed by a
shoulder peak at 650 nm (Fig. 2BeG).
Because Iem amplitude was considerably higher in samples from
older human donor eyes versus young canine retinae, to directly
compare the individual HAI emission data points across all wavelength intervals tested, irrespective of the emission intensity, we
used a linear regression to identify a monotonous transformation to
boost the amplitude of the baseline Iem signal without affecting the
overall shape of the proﬁle (for details, see Supplementary Materials
and Methods). As indicated by the initial HAI analysis, the emission
peak proﬁles of the cBest1-R25X mutant and canine WT-adjusted
were nearly identical, and fell within the SEM range of each other
over most wavelength intervals (Fig. 2D). An analogous linear
regression equation was identiﬁed for cBest1-R25X mutant
(cBest1-R25X adjusted) for its direct comparison to the HAI emission pattern derived from BVMD (hBest1-T6R and -Y227N averaged), revealing a highly overlapping emission spectral proﬁle of
the RPE-associated lipofuscin constituents between human and
canine BEST1-maculopathies (Fig. 2G).
In conclusion, consistent with the ﬁndings in a healthy human
retina (Kennedy et al., 1995; Delori et al., 2001), we now show that
lipofuscin granules accumulate as a function of age in a normal
canine RPE. Interestingly, no apparent disease-speciﬁc HAI emission peaks in either canine or human Best1-mutant RPE were
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Fig. 1. Abnormal buildup of autoﬂuorescent material within RPE cells is a hallmark of canine bestrophinopathies. (A) Accumulation of autoﬂuorescent debris (arrows) is an
age-dependent process in normal canine RPE cells. (B) Confocal scanning laser ophthalmoscopy fundus autoﬂuorescence (cSLO FAF) images of a 20-month-old affected (OS) and an
age-matched wild-type control eye (OD). Note the increased fundus autoﬂuorescence signals scattered throughout the supero-temporal quadrant and adjacent to the optic disc in
the mutant retina. Boxed areas identify regions analyzed ex vivo by Hyperspectral Autoﬂuorescence Imaging (HAI) and immunohistochemistry (IHC). Note the missing autoﬂuorescence over the central lesion (OS). (C) Corresponding SD-OCT images taken at the position of the green line in the above images (B) of the temporal area. A characteristic
bullous separation of the neuroretina from the RPE is demonstrated in the mutant retina; the structurally intact age-matched wild-type control retina is shown for comparison. (D)
Immunostaining against Best1 protein (red) in cryosections from canine wild-type and cBest1-R25X-affected retinae. Note the presence of native autoﬂuorescent granules (green)
and absence of Best1 labeling within affected RPE cells, which appear hypertrophic on the corresponding H&E image; there is a discreet separation of the outer segments from the
apical RPE in the affected retina (arrowhead). Nuclei were stained with DAPI. (E) Confocal microscopy images of a 20-month-old mutant and an age-matched wild-type retinae
showing an excessive accumulation of autoﬂuorescent deposits (arrows) within the affected RPE. ONL: outer nuclear layer; PRs: photoreceptors; RPE: retinal pigment epithelium;
CH: choroid; Scale bars: 10 mm applies to all photomicrographs in (A) and (E); 40 mm applies to all (D) panels.
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Fig. 2. Hyperspectral autoﬂuorescence imaging (HAI) reveals analogous emission proﬁle between human and canine bestrophinopathies. (A) Representative confocal microscopy
images of the native RPE autoﬂuorescence in cryosections from BVMD patients (hBest1-T6R and -Y227N), control subjects (Ctr) of comparable age, and canine bestrophinopathy
model (cBest1-R25X) by HAI analysis. Abundant accumulation of autoﬂuorescent material within RPE cells is a common feature in both human and canine bestrophinopathies. PRs:
photoreceptors; RPE: retinal pigment epithelium; CH: choroid. (B) HAI analysis of endogenous RPE ﬂuorophores in canine cBest1-R25X-affected and age-matched WT RPE revealed
a major emission peak between 536 and 569 nm consistent with lipofuscin signals, followed by a shoulder peak at 650 nm. (C) Statistical analysis conﬁrmed accelerated accumulation of lipofuscin granules in the affected tissue with emission intensity (Iem) 3-fold higher in the mutant vs age-matched control (***p < 0.000002). (D) Direct comparison of
the individual HAI emission data points from cBest1-R25X and cBest1-WT RPE using linear regression across all wavelength intervals. After enhancing the amplitude of the baseline
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detected when compared to age- and retinal location-matched
normal controls (Fig. 2). Although this disease aspect should be
investigated further using other advanced RPE diagnostic tools, our
HAI data strongly suggest that no intrinsic disease-speciﬁc RPE
ﬂuorophores underlie pathophysiology of bestrophinopathies, and
the anomalous increase of lipofuscin bisretinoids observed in
BEST1-retinopathies reﬂects rather an inability of RPE cells to
properly metabolize POS (Singh et al., 2013a), and, in essence,
manifests as a premature senescence of the affected RPE cell
monolayer.
Furthermore, HAI and linear regression analyses exposed
matching spectral signatures between cBest1-R25X and hBest1T6R and -Y227N affected RPE, suggesting a similar composition of
endogenous RPE-associated ﬂuorophores between humans and
dogs. These data support the recent ex vivo ﬁndings from a set of
HAI-proﬁled healthy human eyes, assigning the primary spectral
emission peak to the abundant lipofuscin-melanolipofuscin signal,
and suggesting a presence of a third candidate family of RPEﬂuorophores that requires further biochemical characterization
(Ben Ami et al., 2016). Considering the corresponding hyperspectral
characteristics, the dog should serve as an excellent model system
assisting in further studies on the biochemical composition of the
undeﬁned families of RPE ﬂuorophores.
3.2. Bisretinoids-mediated cholesterol accumulation in BVMD and
cBest model
Studies in polarized ARPE-19 cells demonstrated that A2E, the
most prominent lipofuscin ﬂuorophore, contributes to the accumulation of free and esteriﬁed cholesterol, perturbing its metabolism (Lakkaraju et al., 2007). The mechanism of this bisretinoidinduced cholesterol accumulation within RPE cells was further
explored, signifying the role of trapped cholesterol macromolecules
in the disruption of RPE autophagy (Toops et al., 2015; Tan et al.,
2016). It is unclear however, whether the A2E-mediated cholesterol accumulation reported in vitro contributes to the pathogenesis
and progression of other RPE-linked disorders such as BVMD. To
that end, we examined if the chronic accumulation of lipofuscin
bisretinoids in the Best1-mutant RPE is indeed associated with
increased levels of cholesterol and/or abnormal cholesterol trafﬁcking in human and canine bestrophinopathies (Fig. 3). We found
that lipofuscin granules and free cholesterol (ﬁlipin-positive
puncta) were strongly positively associated in the RPE cells of both
human BVMD (Pearson's correlation coefﬁcient r ¼ 0.85 ± 0.03) and
canine Best1-mutant RPE (r ¼ 0.77 ± 0.02) (Fig. 3A,B). This positive
correlation was in agreement with the emission proﬁle analyses
where the somewhat less intense blue ﬂuorescent signals of ﬁlipinpositive aggregates were co-distributed with the bright green lipofuscin granules (Fig. 3B).
This strong positive correlation between lipofuscin-derived
autoﬂuorescence and cholesterol levels detected ex vivo in canine
and human bestrophinopathies supports the original in vitro observations by Lakkaraju et al. (2007), and strongly suggests that the
perturbed cholesterol metabolism and its extensive downstream
consequences (Toops et al., 2015; Tan et al., 2016) contribute to the
homeostatic imbalance in cBest- and BVMD-RPE. It has been shown
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that the tight control of intracellular cholesterol levels is essential
for proper autophagosome-lysosome interactions, and that excess
of cholesterol within RPE can interfere with intracellular trafﬁcking,
inhibiting lysosomal degradation and consequently, the autophagic
clearance (Lakkaraju et al., 2007; Toops et al., 2015). Furthermore,
as demonstrated in the recent study by Tan et al. (2016), overload of
bisretinoids/cholesterol compromises the protective responses
against complement-mediated damage, leading to mitochondrial
fragmentation and oxidative stress in the RPE cells (Tan et al., 2016).
Detailed experiments focused on the gene expression controlling cholesterol metabolism and dysregulation of lipid homeostasis
in Best1-mutant RPE are beyond the scope of this review. Such
analyses, however, are in progress and constitute the main objective of the next phase of research. As there is no doubt that the
overload of both bisretinoids and cholesterol leads to the severe
perturbations of RPE cell homeostasis, a chronic accumulation of
lipofuscin has been implicated in the pathology of numerous
inherited retinal disorders, including AMD and Stargardt disease
(Spaide, 2003; Cideciyan et al., 2004; Lakkaraju et al., 2007;
Petrukhin, 2007; Tan et al., 2016), and as such constitutes a nonspeciﬁc disease biomarker that is unlikely to trigger per se the
retinal separation in bestrophinopathies.
4. Dysregulation of lipid metabolism and its impact on
subretinal microenvironment in cBest
Besides the increase in unesteriﬁed cholesterol clearly associated with an excess of bisretinoid compounds within Best1-mutant
RPE, comparable distribution and intensity of ﬁlipin staining was
observed across the rest of the tissue in the wild-type and cBest
retinae (Fig. 4A-C). Consistent with the studies on ﬁlipin staining
patterns in human retina, free cholesterol, by far the most predominant form of sterols in the vertebrate retina (Fliesler and
Bretillon, 2010), was broadly distributed throughout all layers of
the canine retina with no difference detected in the cBest1-R25Xaffected vs age-matched WT controls (Fig. 4A,B). However, we did
observe a noticeable difference in the esteriﬁed cholesterol (EC)
levels between cBest model and WT controls after subjecting the
samples to ethanol-based extraction followed by cholesterol
esterase pretreatment (for details, see Supplementary Materials and
Methods) to visualize the EC content (Fig. 4D,E). While in a healthy
human retina EC is mainly associated with Bruch's membrane
(Rudolf and Curcio, 2009; Zheng et al., 2012), in a normal canine
retina this form of sterol was faintly detected within choroid
(Fig. 4D), whereas in cBest retina a substantial increase of ﬁlipinstained EC ﬂuorescence was associated with photoreceptor outer
segment (Fig. 4E, inset). Because ﬁlipin-sterol ﬂuorescence undergoes rapid photobleaching, it is not quantiﬁable; therefore, the
EC ﬁndings were veriﬁed by alternative and more stable neutral
lipid stains, a ﬂuorescent probe BODIPY 493/503 and the classic
lipid-soluble dye Oil Red O (ORO), both known to stain EC (Rudolf
and Curcio, 2009).
A series of experiments with BODIPY 493/503 as well as ORO
conﬁrmed the EC staining pattern in the Best1-mutant retina
(Fig. 4GeL). The bright green ﬂuorescent signals emitted by BODIPY
493/503 were present across all layers in both the normal control

Iem signal (cBest1-WT adjusted), the overlapping emission peak proﬁles of cBest1 mutant and cBest1-WT fell within the SEM range of each other over most wavelength intervals. (E)
HAI of the native RPE autoﬂuorescence from BVMD patients (hBest1-T6R and -Y227N averaged) and control donor eyes demonstrating parallel RPE emission spectra proﬁles. Data
analysis was performed on hyperspectral datasets derived from a mean of four BVMD-affected or control retinae with three cryosections per eye and six ROIs per section
(nBVMD ¼ 72 and nCtr ¼ 72); the color-corresponding shaded areas represent mean ± SEM across the wavelength intervals. (F) HAI-proﬁled intrinsic RPE ﬂuorescence from patients
harboring either hBest1-Y227N or -T6R mutation (plotted individually) and cBest1-R25X model illustrating matching spectral proﬁles among the disease samples from both species,
varying only in the emission intensity, consistently higher in samples from elderly BVMD donors than that of young cBest retinae. (G) HAI emission peak signatures of BVMD
(hBest1-T6R and -Y227N averaged) and cBest1-R25X (cBest1-R25X adjusted) indicating similar proﬁles of RPE-associated autoﬂuorescence constituents in human and canine
bestrophinopathies. Scale bar: 10 mm applies to all (A) panels.
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Fig. 3. Bisretinoids-mediated intracellular cholesterol accumulation in BVMD- and cBest-affected RPE. (A) Representative DIC, native autoﬂuorescence (AF), ﬁlipin-stained free
cholesterol (FC), and AF/FC-merged confocal photomicrographs of RPE cells from human BVMD (hBest1-T6R) and canine model (cBest1-R25X). Lipofuscin granules (green) and free
cholesterol (ﬁlipin-positive puncta, cobalt blue) were highly associated in BVMD and cBest RPE cells. (B) Both the analysis of AF and FC emission proﬁles as well as Pearson
correlation coefﬁcient ‘r’ values indicated a strong positive correlation between endogenous lipofuscin ﬂuorophores (FITC) and ﬁlipin-stained-FC in BVMD-T6R and canine cBest1R25X RPE (r ¼ 0.85 ± 0.03 and r ¼ 0.77 ± 0.02, respectively). Scale bars: 10 mm; magniﬁed images: 5 mm.

and cBest retinae (Fig. 4G,H). In the cBest retina, however, a signiﬁcant increase (*p < 0.05) of EC-BODIPY 493/503 was detected in
the photoreceptor outer segment layer with the highest staining
intensity in the region bordering the inner segment (IS) and at the
OS tips (Fig. 4H,I). Similar EC distribution proﬁle in the mutant
retina was observed with ORO assay where, in addition, numerous
EC-rich inclusions were found within cBest1-R25X mutant RPE and
in the subretinal space as ORO-positive intracellular and extracellular deposits (Fig. 4K arrows, Fig. 4L, higher magniﬁcation). Note
the subtle RPE detachment from the retinal surface in cBest retina
(Fig. 4K,L, arrowheads).
To determine whether the observed dysregulation of cholesterol
homeostasis in the mutant retina is associated with enhanced lipid
peroxidation, we examined the levels of 4-hydoxy-2-nonenal
(HNE), one of the most abundant by-products of lipid peroxidation (Esterbauer et al., 1985). As shown in Fig. 4, increased levels of
HNE-adducts were present in cBest vs age-matched control retinae

(Fig. 4MeO). While in the WT canine retina HNE was primarily
associated with RPE and IS/OS border, in the mutant retina, the
staining pattern of HNE showed in addition a patchy distribution
across OS layer that was characteristic for the retinal regions
located within close proximity to the areas of established subretinal
lesions, and associated with hypertrophic RPE cells featuring their
abnormal scalloped apical membrane (Fig. 4O, arrows).
Numerous studies have documented the essentiality of cholesterol and its tight homeostatic regulation in the maintenance of
outer segment structure and function (Fliesler and Bretillon, 2010;
Albert et al., 2016). Metabolic defect in any aspect of this process
can lead to abnormal accumulation of cholesterol and its toxic
derivatives resulting in retinal degeneration impacting both the
structural integrity and function of POS (Fliesler and Bretillon,
2010). Such alterations are likely due to a combination of factors,
including the requirement for cholesterol in rhodopsin activation,
formation of cholesterol-rich signaling microdomains as well as the
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Fig. 4. Dysregulation of lipid metabolism deﬁnes canine bestrophinopathy as an RPE-photoreceptor interface disease. Spatial distribution of unesteriﬁed (free) cholesterol
visualized by sterol-binding probe ﬁlipin (cobalt blue) in a normal (A) and cBest1-R25X-affected (B) retinae. Note the excess of autoﬂuorescent RPE deposits in the diseased tissue
(B). Filipin-bound free cholesterol was found to be widely distributed across all layers of the canine retina, and appeared to be primarily associated with plasma membrane in ONL
and INL, in contrast to the remaining retinal layers where it was found in both cell membranes and somata (C); tapetum lucidum (TL), a choroidal modiﬁcation characteristic to
carnivores, showed the most intense staining (AeC). (D, E) Histochemical detection of esteriﬁed cholesterol (EC, cobalt blue) in a 12-month-old cBest1-affected vs age-matched
control retina. Note the abnormal buildup of autoﬂuorescent material (yellow-green) within RPE and an increase of EC-ﬁlipin associated with photoreceptor layer in the
mutant (E, close-up). (F) Non-enzyme control: unesteriﬁed cholesterol was extracted with ethanol and sections stained with ﬁlipin, but omitting the cholesterol esterase treatment
(no ﬁlipin labeling). (G, H) Representative retinal cryosections from cBest (H) and age-matched control (G) stained with a ﬂuorescent neutral lipids tracer dye BODIPY 493/503
(green). (I) Quantiﬁcation of EC-BODIPY 493/503 signals in photoreceptor outer segment layer between wild-type and cBest1-R25X-affected retinae. The observed difference was
assessed as statistically signiﬁcant using unpaired t-test (*p < 0.05). (JeL) EC distribution proﬁle in canine wild-type and cBest1-affected retinae assayed with a lysochrome Oil Red
O (ORO, rose). ORO-positive inclusions within the affected RPE (arrows) and in the subretinal space are shown in (K) and (L, close-up); arrowheads point to the discreet separation
of the outer segments from the RPE apical surface in cBest (K, L). (MeO) Anti-4-HNE labeling (red) in the mutant and control retinae. A scattered distribution of HNE-adducts within
outer segments was observed in the affected retina (N and O, close-up) outlining the apical contour of the hypertrophic RPE cells (O, arrows). Nuclei were counterstained with
propidium iodide (A, B, D-H) or DAPI (MeO). INL: inner nuclear layer; ONL: outer nuclear layer; PRs: photoreceptors; RPE: retinal pigment epithelium; TL: tapetum lucidum; Scale
bars: 40 mm (AeH), and 20 mm (D-E close-ups, and J-O).

role of cholesterol in regulating pools of phosphoinositides (Albert
et al., 2016). One such cholesterol-derived compound, 7ketocholesterol (7KCh), is an oxidized form of cholesterol produced by non-enzymatic oxidation at C7 (Moreira et al., 2009;
Rodriguez and Fliesler, 2009). This oxysterol is considered a
potent pro-inﬂammatory agent playing a role in activation of
NLRP3 inﬂammasome and associated with choroidal neovascularization, formation of AMD drusen and aging (Rodriguez

and Fliesler, 2009; Moreira et al., 2009; Rodriguez et al., 2014). At
the molecular level, excess 7KCh not only alters the biophysical
properties of plasma membranes (Bach et al., 2008; Ruggiero et al.,
2012), but also constitutes a ready substrate for esteriﬁcation,
producing a highly unstable esteriﬁed 7-keto molecule that rereleases 7KCh. The higher the degree of fatty acid unsaturation,
the more unstable the esteriﬁed 7-KCh molecule is (Bretillon et al.,
2008; Lee et al., 2015). Thus, the highly unsaturated fatty acids of
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Fig. 5. Compromised cone-associated RPE apical domain and insoluble interphotoreceptor matrix (IPM) in canine bestrophinopathy. (AeJ) A striking absence of cone-associated
RPE apical microvilli was observed across cBest1-R25X-affected retinae as conﬁrmed by immunolabeling against various RPE-speciﬁc markers. (A, B) Anti-MCT1 (green) and
anti-BEST1 (red) double IHC labeling; Note the absence of BESTROPHIN 1 basolateral labeling in the mutant retina, accompanied by a dramatic retraction of RPE apical projections
(B). (C, D) Representative images of RLBP1 (a.k.a. CRALBP) immunolabeling (red); native lipofuscin ﬂuorescence is visualized as yellow-green RPE inclusions in the mutant RPE (D).
(E, F) Direct comparison of anti-EZRIN immunostaining (red) between canine wild-type and cBest1-R25X-affected retinae. The massive inclusions (yellow-green) within the mutant
RPE represent native lipofuscin (F). (GeJ) Confocal photomicrographs of anti-EZRIN (red) and peanut agglutinin lectin (PNA, cyan) double-labeling in mutant (H and J) and agematched controls (G and I). Note that in the WT retinae PNA-stained insoluble extracellular matrix closely invest cone-associated RPE apical microvilli (GeI); in the cBest
mutant, however, the structure of both the intrinsic RPE-associated- and the external IPM-derived cone-speciﬁc domain is largely compromised (H, J), affecting the adhesive forces
of RPE-photoreceptor complex. ONL: outer nuclear layer; MV: microvilli; RPE: retinal pigment epithelium; CH: choroid. Scale bars: 20 mm (AeF) and 10 mm (GeJ).

the photoreceptor OS would provide a highly unstable variant of
this compound, compromising the subretinal microenvironment,
and consequently, the interplay of RPE-photoreceptor complex.
Such changes in concentration of metabolites surrounding POS may
also disturb the hydration, bonding properties and viscosity of the
interphotoreceptor matrix (IPM), and misregulate the volume of

subretinal space affecting retinal adhesion (Marmor, 1994; Pianta
et al., 2003; Milenkovic et al., 2015).
It is possible, therefore, that the altered distribution and
increased levels of cholesterol esters and HNE-adducts within
photoreceptor layer of the cBest1-affected retinae may indeed
indicate a compromised IPM domain, exposing thereby a new role
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Fig. 6. Impaired RPE-cone interaction and photoreceptor alignment in canine bestrophinopathy. (A, B) Confocal photomicrographs of canine wild-type (A) and cBest1-R25X/
P463fs-affected (B) retinae immunolabeled for human cone arrestin (hCAR, green) and PNA lectin (red). PNA-positive cone extracellular matrix sheaths tightly embrace the E2F1labeled cone-speciﬁc RPE projections, extending along the outer- and toward the inner segment of cone photoreceptor cells in the control retina (A, close-up); in the cBest mutant,
this IPM domain appears ruptured, exposing OS to the extracellular space (B, close-up). Together with the impairment in structural integrity of cone-speciﬁc IPM escheatment, cone
photoreceptor OS lose their proper orientation (B), necessary for the normal interactions with RPE cells. (C, D) Multi-label IHC images of canine wild-type (C) and cBest mutant (D)
retina illustrating bilayered extracellular compartmentalization of the cone-speciﬁc escheatment responsible for a normal apposition of RPE-cone OS (C, inset). This well-deﬁned
extracellular structure was lost in the affected retinae (D), revealing a dearth of the intrinsic RPE-associated apical microvillus layer, accompanied by rather fragmented external
insoluble cone-speciﬁc matrix domain (D, close-up). Cone OS stripped of their protective sheaths appeared undermined with no direct contact with the underlying RPE (B, D). hCAR:
human cone arrestin (shown in green A-D, and delineated by green arrows on the magniﬁed images); PNA: peanut agglutinin lectin (shown in red A-B, and deﬁned by red arrows on
the corresponding close-ups; PNA in C-D is represented in cyan, and by cyan-colored arrows on the magniﬁed photomicrographs); E2F1: E2F transcription factor 1 (shown in red CD, and indicated by red arrows in C inset). ONL: outer nuclear layer; PRs: photoreceptors; RPE: retinal pigment epithelium. Scale bars: 20 mm (A, B), 10 mm (C, D), and 1 mm (applies
to all magniﬁed images). Photomicrographs C & D: modiﬁed from Guziewicz et al. Adv. Exp. Med. Biol. (in press).

of Best1 in modulating the homeostatic milieu of subretinal space.
While the excess of EC could function as an atypical chronic inﬂammatory stimulus interrelated to the impaired calcium signaling
and ﬂuid ﬂow, such as 7-KCh (Lakkaraju et al., 2007; Moreira et al.,
2009; Wang et al., 2010; Singh et al., 2013a; Strauss et al., 2014), the
lipoperoxidation product, HNE, may act as a stress signaling
molecule (Shen et al., 2007; Perluigi et al., 2012), both predisposing
retina to the loss of adhesive forces in response to these pathological stimuli.
5. Bestrophinopathy: an RPE-photoreceptor interface disease
5.1. Compromised RPE-photoreceptor interaction in cBest
The RPE-photoreceptor interface is an area of crucial importance
to proper retinal function (Hageman and Johnson, 1991).

Dysregulation of lipid metabolism documented in cBest1-mutant
retina pointed to the presence of biochemical perturbations in
the subretinal space reﬂecting homeostatic imbalance in the delicate IPM microenvironment. To gain additional insight into the
spectrum of abnormalities at the RPE-photoreceptor interface in
cBest, and identify further potential factors that may play a role in
lesion formation in bestrophinopathies, a set of RPE-, photoreceptor- and IPM-speciﬁc markers were used for IHC evaluation of
cBest vs control retinae (Fig. 5). A striking difference between the
two was the retraction of RPE apical projections (a.k.a. microvilli,
MV) in all cBest1-R25X-affected retinae as evidenced by the
absence of MV labeling using a set of markers known to be
expressed at the RPE apical membrane and along its extensions
(Fig. 5AeF). Speciﬁc immunostaining against MCT1 (Monocarboxylate Transporter, Member 1), RLBP1 (Retinaldehyde Binding
Protein 1), and EZRIN was present in both the structurally normal
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and mutant retinae, but in the latter the immunolabeling was
limited to the apical surface of RPE monolayer, which lacked the MV
extensions that interdigitated with POS (Fig. 5B, D, and F). This
ﬁnding was age- and sex-independent and observed in all canine
BEST1 mutant eyes examined after disease onset, in both the central
retina as well as in the periphery. In contrast, the immunolabeling
pattern of EZRIN, RLBP1 and MCT1 in cBest carrier retinae was
comparable to that of the WT (data not shown). Confocal imaging of
the mutant retinae immunolabeled by anti-EZRIN in combination
with PNA lectin, known for its selective binding to the cone insoluble extracellular matrix microdomains (Johnson and Hageman,
1991; Mieziewska et al., 1993), conﬁrmed MV retraction and
revealed disordered and considerably disrupted cone-associated
IPM ensheathment (Figs. 5GeJ, and 6AeD). While the retraction
of the longer RPE processes embracing cones was evident
throughout the cBest1 mutant retinae, in both regions with bullous
detachments as well as in non-detached areas, the much shorter
residual MV associated with the longer rod outer segments were
occasionally seen. However, the RPE apical extensions associated
with rods are much shorter and ﬁner than the cone-ensheathing
processes, hence somewhat more difﬁcult to visualize and track;
yet at higher magniﬁcation, these small structures of rodassociated RPE extensions appeared disordered and interlaced
(Fig. 5J). An expanded immunohistochemical study deﬁned a
bilayered extracellular compartmentalization of the cone speciﬁc
escheatment responsible for a normal apposition of RPE-cone OS
(Fig. 6C-D). This well-deﬁned extracellular structure was lost in the
cBest1-affected retinae, revealing a dearth of the intrinsic RPEassociated apical microvillus layer accompanied by a fragmented
external cone-speciﬁc matrix domain (Fig. 6CeD, insets). As a
result, cone OS stripped of their protective sheaths appeared
undermined with no direct contact with the underlying RPE (Fig. 6).
The structural abnormalities related to the impaired microvillar
ensheathment of photoreceptor outer segment tips and compromised insoluble IPM constitute two major pathological culprits
responsible for weakening of the RPE-neuroretina physical and
electrostatic interactions (Mieziewska, 1996; Bonilha et al., 2006).
Despite the fact that IPM occupies a strategic location in the retina,
for many years it was considered as an amorphous substance of
unknown function and signiﬁcance. We now know that this intricate yet highly organized structure with interconnected domains
designed to meet the speciﬁc needs of both rods and cones, is
critical for maintaining the homeostatic milieu of subretinal space
and formation of an adhesive bond between RPE and photoreceptors (Johnson and Hageman, 1991; Mieziewska et al., 1993;
Ishikawa et al., 2015). The key location between RPE apical surface and photoreceptors allows IPM to fulﬁll a range of biochemical
and physical tasks fundamental for normal retinal function, among
which the most critical ones like regulation of oxygen, nutrients
and retinoid transport or preservation of cytoskeleton and retinal
adhesion by providing electrostatic support for photoreceptors
(Johnson and Hageman, 1991; Mieziewska et al., 1993; Hauck et al.,
2005; Ishikawa et al., 2015). It is therefore not unexpected that any
genetic or metabolic defect found in the soluble and insoluble
components of IPM play a role in the etiology of retinal degenerative disorders, such as IMPG1-and IMPG2-associated vitelliform
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macular dystrophy (Manes et al., 2013; Meunier et al., 2014;
Ishikawa et al., 2015).
The dramatic retraction of the intrinsic RPE apical microvilli that
underlies the loss of bilayered extracellular compartmentalization
is of particular importance to the molecular pathology of bestrophinopathies. As highlighted earlier, the RPE performs a series of
highly specialized tasks essential for homeostasis and structural
integrity of the neural retina, including bidirectional transepithelial
transport, supplying nutrients into and eliminating waste products
from the photoreceptor layer, daily POS phagocytosis, light absorption, transport and regeneration of visual pigment; and all of
these functions involve RPE microvilli that normally extend from its
apical surface interdigitating with and tightly investing the POS
(Bok, 1993; Bonilha et al., 2004, 2006). It is also important to note
that these RPE projections greatly increase the apical surface area
and, consequently, the number of transport and signaling molecules it contains, thereby enhancing the epithelial functional capacity (Bonilha et al., 2004; Miura et al., 2015). Thus, it is very likely
that most of the major hallmarks of bestrophinopathies, e.g. disrupted ion and ﬂuid transport (Sun et al., 2002; Milenkovic et al.,
2015), impaired phagocytosis (Singh et al., 2013a), abnormal
photoreceptor equivalent thickness (PET) documented in BVMD
patients (Kay et al., 2012), an excessive build-up of autoﬂuorescent
debris in the subretinal space, and ﬁnally, the RPE-neuroretinal
detachment and formation of serous lesions (Boon et al., 2009a,
2009b), arise directly from the dearth of properly formed microvilli, and impaired interaction/adhesiveness with OS. We posit that
these salient interface defects may also account for the abnormal
EOG and Arden ratio present clinically in bestrophinopathy patients (Pianta et al., 2003; Boon et al., 2013).
5.2. Underdeveloped RPE apical domain and lesion formation in
bestrophinopathies
Based on these fresh insights from the spontaneous canine
model of BEST1-maculopathies, it is reasonable to hypothesize that
the cone-associated microvilli as well as the insoluble cone matrix
sheaths are more sensitive to the biochemical changes in the
delicate subretinal microenvironment and retract ﬁrst, which
would explain the predilection of the highly metabolically active
cone-packed macular region to its primary detachment in human
and canine bestrophinopathies. Alternatively, it is possible that the
BEST1 mutations impair the ability of RPE apical cone sheaths to
form along with the shorter rod-associated MV processes. To test
the premise, comparable IHC studies were performed in young (6week-old) cBest retinae before disease onset, yet at the time point
when the canine retina completes its development (Acland and
Aguirre, 1987).
As shown in Fig. 7, both the immunolabeling against MCT1 and
EZRIN revealed an underdeveloped RPE apical domain in the young
cBest retinae, with only a few longer RPE microvilli and a highly
disorganized distribution of EZRIN (Fig. 7AeD). In comparison to
the age-matched controls, the 6-week-old cBest retina showed
greatly diminished expression of EZRIN at the RPE apical surface,
accompanied by an anomalous increase of EZRIN-positive signals
associated with microvilli of Müller cells (Fig. 7D, close-up). While

Fig. 7. Underdeveloped RPE apical domain underlies formation of subretinal lesions in canine bestrophinopathies. (AeD) IHC evaluation of 6-week-old cBest1-R25X/P463fsaffected and age-matched wild-type control retinae showed underdevelopment of RPE apical domain in cBest mutant, as demonstrated by comparative labeling with anti-MCT1 (A,
B), and anti-EZRIN (C, D). In sharp contrast to the young, yet fully matured WT canine retina (A), the age-matched mutant one exhibited loss of the longer MCT1-positive RPE apical
microvilli, even before the onset of clinical disease (B, close-up); note the absence of BESTROPHIN 1 labeling (B) compared to the robust Best1 basolateral signals detected in the
control RPE (A, red). (C, D) Contrary to the speciﬁc anti-EZRIN immunostaining in the WT (C), evaluation of the mutant retina revealed largely diminished ﬂuorescent signals at the
RPE apical surface with only a few EZRIN-positive RPE processes (D, arrows). Note the dramatic increase of EZRIN labeling associated with microvilli of Müller cells (D, close-up). (E,
F) Although not obvious on H&E images, the cone outer segments of cBest-affected retinae already lack the uniform regularity when immunolabeled with hCAR (F, green) and
compared to the WT control (E). Scale bars: 20 mm (AeF), and 10 mm (magniﬁed images in A-D). Photomicrographs D-F: modiﬁed from Guziewicz et al. Adv. Exp. Med. Biol. (in press).
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Fig. 8. EZRIN immunolabeling in WT, BVMD, and ARB hiPSC-RPE. (AeC) Immunohistochemical analysis of WT hiPSC-RPE showed strong expression of EZRIN with vertically
oriented, apical localization. (DeF) Similar expression and localization of EZRIN was observed in BVMD hiPSC-RPE. (GeI) In the ARB hiPSC-RPE, harboring compound heterozygous
mutation in BEST1, MV are smaller in height compared to the WT hiPSC-RPE, and express EZRIN in a punctate fashion within a thin apical band. XZ and YZ labeled images are
representative images for X-Z and Y-Z optical sections. Scale bar: 10 mm applies to all panels.

at this early time point cBest1-R25X/P463fs-affected retinae
appeared histologically intact, the hCAR-labeled cone OS seemed
more fragile and susceptible to destabilization following the natural course of disease.
These intriguing insights open a new avenue toward understanding the pathogenesis of bestrophinopathies and warrant
further studies on RPE-PRs complex before disease onset. A number
of research studies provided strong evidence that EZRIN is a major
determinant in the maturation of surface differentiations of RPE,
promoting morphogenesis of apical microvilli (Bonilha et al., 1999;
Saotome et al., 2004; Miura et al., 2015). Our ﬁndings in the canine
model support these results and strongly suggest that underdevelopment of cone-associated apical projections along with abnormalities of the insoluble cone extracellular matrix domain
constitutes a key factor that underlies formation of the macularselective subretinal lesions in bestrophinopathies. The fact that
these prominent structural alterations associated with cone
ensheathment are observed in cBest dogs as early as 6 weeks of age
would also explain the early onset of ARB and BVMD along with the
predisposition of the macular region to its primary detachment in
affected dogs and patients.
5.3. RPE microvilli in ARB- and BVMD patient-speciﬁc hiPSC-RPE
In vitro, BVMD patient-speciﬁc human induced pluripotent stem
cell-derived RPE (hiPSC-RPE) have been shown to successfully
recapitulate several key cellular features of Best disease pathophysiology, including delayed POS degradation, increased accumulation of autoﬂuorescent material after POS feeding, changes in
endoplasmic reticulum-dependent Ca2þ homeostasis, and
impaired ﬂuid ﬂux in response to physiological stimuli (Singh et al.,
2013a, 2015). Both hiPSC-RPE and cBest models have complemented each other not only in gaining insights into BVMD

pathophysiology, but also in testing potential therapeutic strategies
(Singh et al., 2015). Using this hiPSC model system, we have followed up on observations from the cBest model to look for differences in the apical processes of WT, BVMD and ARB hiPSC-RPE
cultures. Human iPSC-RPE from all hiPSC sources were immunolabeled for EZRIN (Singh et al., 2013b, 2015), which was present in a
thick, vertically oriented band along the apical region of WT hiPSCRPE, consistent with its localization within apical processes
(Fig. 8A-C). BVMD (hBEST1-N296H) hiPSC-RPE also demonstrated a
vertically oriented apical band of EZRIN immunolabeling
(Fig. 8DeF); however, in ARB hiPSC-RPE (hBEST1-R141H/A195V)
EZRIN immunolabeling was less prevalent, punctate, and localized
within a much thinner apical band (Fig. 8GeI), akin to observations
made in the cBest model.
Given that EZRIN immunostaining appeared relatively similar
between WT and BVMD hiPSC-RPE, transmission electron microscopy (TEM) was performed on ultra-thin sections of RPE to further
assess whether differences exist between the apical microvilli of
WT and BVMD hiPSC-RPE. TEM analysis showed decreased length
and density of microvilli in BEST1-N296H vs WT hiPSC-RPE (Fig. 9).
Given that the hiPSC-RPE was cultured in isolation as homogenous
monolayers, these differences in apical RPE microvilli between WT,
BVMD, and ARB hiPSCs are independent of interactions with cone
photoreceptors.
6. Pathogenesis of early vitelliform lesions: insights from
canine model
The structural and metabolic defects identiﬁed in the cBest
model certainly contribute to, if not directly trigger, the separation
of the neuroretina from the underlying RPE, the salient structural
abnormality of bestrophinopathies. Further studies on molecular
pathology of early focal and multifocal lesions conﬁrmed the range
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Fig. 9. TEM of WT and BVMD hiPSC-RPE. TEM analysis of WT hiPSC-RPE (A) and BVMD (BEST1-N296H) hiPSC-RPE (B) reveal shorter and more sparse microvilli in BEST1-N296H
versus WT control hiPSC-RPE. Scale bar: 1 mm.

of abnormalities as directly associated with subretinal detachment
in cBest mutant retinae (Fig. 10). We found an abnormal accumulation of lipofuscin material within RPE cells consistently associated
with both the early and more advanced cBest lesions, remarkably
aggregating not only at the detachment site, but also in its close
vicinity (Fig. 10AeE). The more advanced cBest lesions represent
longer standing retinal disassociations, where the autoﬂuorescent
debris starts to occupy subretinal space in transition to the pseudohypopyon stage (Fig. 10D,E). A noticeable increase in EC-BODIPY
493/503 was found to be associated with the photoreceptor layer in
all early lesions examined, evident at the site of retinal separations
and within still intact areas adjoining to the lesions (Fig. 10C). A
series of IHC evaluations conﬁrmed absence of microvillar elongations accompanied by a strikingly undulated RPE apical surface at
the sites of detachments mapped in vivo by cSLO/SD-OCT
(Fig. 10D,E). The primary lesion has a tendency to expand and
secondary small satellite lesion(s) can be observed in its immediate
vicinity often with a subtle retinal elevation between the individual
separations (Fig. 10F,G). Eventually, after a prolonged serous
detachment, the cellular debris accumulating in the subretinal
space will constitute the solid phase of the gravitating pseudohypopyon material in the advanced disease. The rate of disease progression from early vitelliform to pseudohypopyon stage varies
greatly between individuals and factors responsible for this
mechanism are currently under investigation.
Best1 is a pentameric channel protein with deﬁned roles in
mediating anion transport and regulating calcium signaling in RPE
cells (Kane Dickson et al., 2014; Yang et al., 2014; Strauss et al.,
2014). Since intracellular calcium has been implicated to play
important role in microvilli formation (Miura et al., 2015), the
altered calcium homeostasis caused by Best1 dysfunction could
underlie the defective villus architecture detected in cBest
(Figs. 5e7, and 10) and hiPSC-RPE (Figs. 8 and 9) models, and reported in BVMD (Mullins et al., 2007) (Fig. 11). While the studies on

ARB- and BVMD patient-speciﬁc hiPSC-RPE will further explore
Best1 interactors as well as speciﬁc cellular pathways affected by
dysregulated calcium signaling (Singh et al., 2013a, 2015), the
studies on the natural canine model will continue to provide vital
insights into the mechanism and kinetics of retinal detachment, the
salient clinical structural abnormality of bestrophinopathies. Based
on the studies to date, the proposed mechanism of lesion formation
in canine and human bestrophinopathies is summarized in Fig. 11.

7. Concluding remarks and future directions
The pathological mechanisms of pediatric retinal disorders, such
as juvenile BEST1-associated maculopathies, are often challenging
to explore; this can be attributed to the shortage of quality biospecimens harvested at the disease-relevant stages and, until now,
to the dearth of bona ﬁde animal models to carry out mechanistic
studies. Genetic disorders caused by mutations in a single locus, yet
resulting in a variable clinical expression, pose perhaps the greatest
challenge, which can be extremely difﬁcult to address if the
laboratory-induced animal models fail to recapitulate the human
disease (Marmorstein et al., 2004; Marmorstein and Marmorstein,
2007; Zhang et al., 2010; Xiao et al., 2010). It is now possible,
however, to undertake such studies with the canine BEST1 disease
model as it shares all the fundamental aspects with human
bestrophinopathy, including the salient predilection of subretinal
lesions to the canine macular region (Guziewicz et al., 2007, 2011,
2012; Beltran et al., 2014; Singh et al., 2015).
Here, we provide key insights into the complex molecular pathology of BEST1-related disorders, revealing factors predisposing
macula to its primary detachment in BEST1-linked maculopathies,
which may also account for the abnormal EOG and Arden ratio in
BVMD and ARB patients. In view of the fact that RPE monolayer
exhibits a considerable mosaicism (Burke and Hjelmeland, 2005),
including not only topographic variations and regional
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Fig. 10. Canine BEST1-associated maculopathy is a disease of an RPE-photoreceptor interface. (A) Confocal photomicrograph of an early pre-vitelliform lesion. The section was
stained with wheat germ agglutinin (WGA, red) and DAPI (blue). Bright green ﬂuorescent signals of lipofuscin granules (native LF) were found to be associated with RPE cells
directly underlying the primary neuroretinal disruption as well as its immediate surrounding areas. (B) Cryosection from a 30-month-old cBest1-R25X-affected dog with more
advanced subretinal lesions comparable to stage II (vitelliform) in BVMD. BEST1-deﬁcient RPE cells accumulate ﬂuorescent debris subjacent the serous retinal detachment. (C)
Retinal cross-section through an early vitelliform lesion from a 25-month-old dog harboring premature stop mutation (R25X) in the canine BEST1. The section was pretreated with
ethanol before applying BODIPY 493/503 (green) and propidium iodide (red) for nuclear counterstaining. An evident increase of EC-BODIPY was recorded within the detached and
more intact areas adjoining to the lesion. (D) Advanced vitelliform lesion immunolabeled with anti-EZRIN (red) and stained with DAPI (blue). Note the striking undulation of the RPE
apical membrane (white curved arrows), absence of EZRIN-positive RPE apical projections, and beginning of a buildup of autoﬂuorescent debris in the subretinal space (native LF
ﬂuorescence). (E) Similar cBest lesion in a 25-month-old cBest1-R25X-affected dog labeled with anti-PRPH2 (red). Peripherin-stained photoreceptor debris occupy RPE apical
surface delimiting its scalloped nature and RPE cell hypertrophy after the serous neuroretinal detachment. Cellular debris appear as yellowish subretinal aggregates. (F, G) Montage
confocal photomicrographs of a large subretinal lesion and a satellite microlesion in vitelliform stage labeled with WGA (red) and anti-Rhodopsin (Rho, green) (F) or a combination
of peanut agglutinin lectin (PNA, red) and anti-cone arrestin (hCAR, green) (G). Both the Rho- and hCAR-positive cellular debris were detected in the subretinal space of the mutant
retinae. Nuclei were counterstained with propidium iodide (C) or DAPI, respectively. INL: inner nuclear layer; ONL: outer nuclear layer; RPE: retinal pigment epithelium. Scale bars:
100 mm (A, F, and G), and 40 mm applies to (BeE) panels.

specializations, but also cell-cell heterogeneity in gene expression
(Mullins et al., 2007) and individual ability to support adjacent
photoreceptors, single cell proﬁling may be required for elucidating
the multifocal form of bestrophinopathy, in order to gain a full
understanding of the spectrum of changes that each RPE cell must

withstand before losing its direct interacting apposition.
Considering the rapid progress in hiPSC research, the key insights from a reliable animal model and its immediate veriﬁcation
in patient-speciﬁc hiPSC-RPE generate an exceptional momentum
that will accelerate progress to the clinical applications (Guziewicz
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Fig. 11. Proposed mechanism of lesion formation in canine and human bestrophinopathies.
(A) Schematic representation of canine macula (a.k.a. area centralis) illustrating the normal RPE-photoreceptor apposition, sustained by intra- and extracellular ionic equilibria
(NORMAL MACULA, left panel). Ionic imbalance caused by mutation(s) in BEST1 gene initially affects RPE cell homeostasis, including expression of Caþþ-dependent molecules (i. a.,
EZRIN). Impaired expression of EZRIN, the key determinant in the maturation of surface differentiations of RPE, leads to the underdeveloped RPE apical surface with fewer and
rather immature microvilli that are not capable of investing and supporting the photoreceptor outer segments (BESTROPHINOPATHY: SUBCLINICAL DISEASE, middle panel). Once the disease
progresses, RPE cells gradually hypertrophy and lose their ability to mediate the ionic milieu of subretinal space. The cumulative effect of biochemical insult, accompanied by the
structural abnormalities at the RPE apical surface weakens the adhesive forces of RPE-photoreceptor complex, which consequently results in separation of neuroretina from the RPE,
and formation of serous lesion (PREVITELLIFORM STAGE, right panel). (B) Schematic representation of human fovea. This rod-free structure is densely packed with cone photoreceptors
tightly enveloped by RPE apical microvilli (cMV) and ensheathed in cone-speciﬁc interphotoreceptor matrix (c-IPM) (NORMAL FOVEA, left panel). Due to the extremely high density of
cones at this site, their outer segments in vivo will appear thinner in diameter, resembling rod photoreceptors; however, the cone outer segments are shorter than that of rods, and
the RPE apical projections form long pedicles in order to reach them (cMV, red). The downstream effects of BEST1 mutation(s) manifest as both the ionic disequilibrium within RPE
cells (and later within the adjacent subretinal space) and structural disintegration associated with RPE-derived cone ensheathment (BESTROPHINOPATHY: SUBCLINICAL DISEASE, middle
panel). As a consequence, the underdeveloped cone-associated RPE apical extensions are not able to physically support cone OS, which together with the reduced RPE functional
capacity resulting directly from the decreased apical surface area, leads to the formation of macular-selective subretinal lesions at this highly metabolically active site (BESTROPHINOPATHY: PREVITELLIFORM STAGE, right panel). The compromised cone-associated insoluble IPM (c-IPM, cyan) may result from the chronic metabolic insult perturbing the delicate
microenvironment of subretinal space and, secondarily, from the physical disassociation of the RPE-photoreceptor complex. The rate of disintegration of this extracellular matrix
may constitute an important factor directly related to the expansion of vitelliform lesion and disease progression. Cone: cone photoreceptor cell; Rod: rod photoreceptor cell; c-IPM:
cone-associated interphotoreceptor matrix; cMV: cone-associated microvilli; rMV: rod-associated microvilli; RPE: retinal pigment epithelium; BM/CH: Bruch's membrane/choroid.

et al., 2013; Sinha et al., 2016). As a complementary system, hiPSCRPE-based in vitro modeling of BVMD provides a platform for
assessing pharmacological and gene therapy based interventions
(e.g., lengthening of apical microvilli as a therapeutic outcome
measure). As such, homeostatic restoration of RPE-photoreceptor
interface should be considered an important outcome measure in
the assessment of experimental therapies for bestrophinopathies
that will warrant the sustained disease reversal.
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